Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial

NCT03342495 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 337

Last updated 2023-06-12

No results posted yet for this study

Summary

The Transition Navigator Trial (TNT) is a pragmatic randomized controlled trial evaluating the effectiveness of usual care plus a patient navigator service versus usual care plus newsletters and other educational materials, to improve transition outcomes among adolescents aged 16-21 who have chronic health conditions requiring transfer to adult specialty care.

The study will provide urgently needed data to guide health care providers and policy makers regarding the provision of coordinated transition care. These results have the potential to:

1. Change care delivery
2. Improve health outcomes
3. Improve the experiences of young adult transition to adult care

Conditions

Interventions

OTHER

Patient Navigator

Social worker/Patient Navigator will be assigned to follow youth in adult care for up to 24 months to assist youth adapt and attach to adult delivered healthcare

OTHER

Usual Care

Whatever processes are in place in a variety of clinics to support transfer from pediatric to adult care in the pediatric clinics

Sponsors & Collaborators

  • Alberta Health services

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • University of Calgary

    lead OTHER

Principal Investigators

  • Susan Samuel, MD, MSc · University of Calgary

  • Gina Dimitropoulos, PhD · University of Calgary

  • Andrew Mackie, MD · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-06
Primary Completion
2021-08-31
Completion
2021-09-07

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03342495 on ClinicalTrials.gov